• Explore /
  • Poster
  • / <span>Pan-cancer B- and T-cell transcriptome analysis of CXCL13 as a predictive marker for immune checkpoint inhibitor response.</span>

Pan-cancer B- and T-cell transcriptome analysis of CXCL13 as a predictive marker for immune checkpoint inhibitor response.

Abstract Poster

Authors

Yu Fujiwara

Yu Fujiwara

Roswell Park Comprehensive Cancer Center, Buffalo, NY

Yu Fujiwara , Shumei Kato , Daisuke Nishizaki , Hirotaka Miyashita , Suzanna Lee , Mary K Nesline , Jeffrey M Conroy , Paul DePietro , Sarabjot Pabla , Razelle Kurzrock

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics—Immunotherapy

Sub Track

Tissue-Based Biomarkers

Clinical Trial Registration Number

NCT02478931

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr 2626)

DOI

10.1200/JCO.2024.42.16_suppl.2626

Abstract #

2626

Poster Bd #

105

Abstract Disclosures

Similar Posters

Poster

2024 ASCO Gastrointestinal Cancers Symposium

A transcriptomic approach to explore the immune landscape of patient with pancreatic ductal adenocarcinoma with prognostic impact.

A transcriptomic approach to explore the immune landscape of patient with pancreatic ductal adenocarcinoma with prognostic impact.

First Author: Jose Antonio Lopez Guerrero

First Author: Yanyan Lou

First Author: Sofia Genta

First Author: Yu Fujiwara